Cholera vaccine is 86 percent effective, study reports

May 29, 2014
Image credit: Wikipedia.

A cheap and easy to deliver oral vaccine against cholera is 86 percent effective in preventing the infection which causes severe diarrhea and can be fatal, researchers said Thursday.

Some 1.4 billion people around the globe were at risk for cholera in 2012, according to World Health Organization (WHO).

Cholera is caused by a bacterium, Vibrio cholerae, which can spread through the water supply in places where sanitation and hygiene are poor.

The study in the May 29 edition of the New England Journal of Medicine was the first to measure the effectiveness of a vaccine called Shanchol in response to a under field conditions in Guinea.

Previously, the vaccine had been tested only under experimental conditions in Kolkata, India.

The research in Guinea, carried out by Doctors Without Borders (Medecins Sans Frontieres), involved more than 300,000 doses of the two-dose vaccine, administered during a cholera outbreak in 2012.

It was 82 to 86 percent effective, and carried few side effects.

However, researchers were unable to compare one versus two doses in preventing cholera, and it remains unknown how the long the vaccine can remain effective at room temperature.

"Furthermore, can Shanchol be used in pregnancy and in children younger than one year of age?" asked a pair of doctors in Haiti and the United States, in an accompanying Perspective article in the journal.

"Although WHO recommendations suggest targeting pregnant women at high risk for cholera, the manufacturer has not approved use of the vaccine in pregnancy, and there are no guidelines for children under one year old."

There are three cholera vaccines currently on the world market.

Shanchol is less expensive and easier to store than another leading vaccine, Dukoral, and the two are comparable in terms of effectiveness.

Shanchol costs $1.85 per dose, compared to Dukoral at $5.25 per dose. Both may offer some protection against for up to five years.

The two vaccines have been approved by the World Health Organization for purchase by UN agencies. A third , mORCVAX, is licensed and produced only in Vietnam.

More than 1.6 million doses of Shanchol have already been distributed worldwide in the past three years.

The WHO has stockpiled two million doses and the Global Alliance for Vaccines and Immunization (GAVI) has pledged support for 20 million doses over the next five years, said the editorial, warning that millions more doses are needed.

Explore further: Haiti to test cholera vaccine

Related Stories

Haiti to test cholera vaccine

October 19, 2011

Haiti's health ministry is preparing to test a cholera vaccine on a hundred people, a year after an epidemic killed over 6,500 people, officials said Wednesday.

Pioneering use of oral cholera vaccine during outbreak

October 17, 2013

In a report publishing October 17th, 2013 in PLOS Neglected Tropical Diseases, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and its scientific research arm, ...

Vaccine confers long-term protection against cholera

October 16, 2013

A clinical study published in the Lancet Infectious Diseases shows for the first time that an oral cholera vaccine (ShancholTM) provides sustained protection against cholera in humans for up to five years. The study showed ...

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.